Inixi Bio
San Francisco, United States · Founded 2024
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- inixi.bio
- Last Round
- SeedMay 2025
- Rounds
- 1
About
Inixi Bio is a San Francisco-based biotechnology company focused on early cancer detection through liquid biopsy diagnostics, reflected in its stated mission of "stopping cancer at stage zero." Co-founded by Jonathan Spalding, the company was part of QB3's early-stage mentoring cohort for Bay Area life-science startups and has been featured in MBC BioLabs community programming alongside other liquid-biopsy and cancer-diagnostics ventures.
Summary
Inixi Bio is a Biotech company based in San Francisco, United States, founded in 2024. Its most recent funding was a Seed round in May 2025. Investors include SOSV.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...